ClinVar Miner

Submissions for variant NM_002700.3(POU4F3):c.384_387dup (p.Ser130fs)

dbSNP: rs1581278366
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000825604 SCV000966947 likely pathogenic Rare genetic deafness 2018-03-07 criteria provided, single submitter clinical testing The p.Ser130fs variant in POU4F3 has not been previously reported in individuals with hearing loss and was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein?s amino acid sequence beginning at position 130 and leads to a premature termination codon 43 amino a cids downstream. This termination codon occurs in the last exon and is likely to escape nonsense mediated decay resulting in a non-functional truncated protein. Heterozygous loss of function of the POU4F3 gene is strongly associated with he aring loss. In summary, although additional studies are required to fully establ ish its clinical significance, the p.Ser130fs variant is likely pathogenic. ACMG /AMP Criteria applied: PVS1_Strong, PM2

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.